AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference

About this update from Avita Medical, Inc.

VALENCIA, Calif. , Nov. 25, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that Jim Corbett , Chief Executive Officer, will present at the at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 , at 11:30 a.m. Eastern Time . A live webcast of the fireside chat will be accessible under the Events & Presentations section of the Company's website at https://ir.avitamedical.com . A replay of the webcast will be available following the conclusion of the event. About AVITA Medical, Inc. AVITA Medical® is a commercial-stage regenerative medicine company transforming the standard of care in wound care management and skin restoration with innovative devices. At the forefront of our platform is the RECELL® System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. RECELL harnesses the regenerative properties of a patient’s own skin to create Spray-On Skin™ Cells, delivering a transformative solution at the point-of-care. This breakthrough technology serves as the catalyst for a new treatment paradigm enabling improved clinical outcomes. In the United States , AVITA Medical also holds the exclusive rights to market, sell, and distribute PermeaDerm®, a biosynthetic wound matrix, and Cohealyx™, an AVITA Medical -branded collagen-based dermal matrix. In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns, full-thickness skin defects, and vitiligo. The RECELL System is TGA-registered in Australia , has received CE mark approval in Europe , and has PMDA approval in Japan . To learn more, visit www.avitamedical.com . Authorized for release by the Chief Financial Officer of AVITA Medical, Inc. Investor & Media Contact: Jessica Ekeberg Phone +1-661-904-9269 [email protected] [email protected] Source: AVITA Medical

View stock analysis, news, and events for Avita Medical, Inc.